GlassScriptPhysician profile
Sarah E Kreider
NPI 1942431911
$925.17
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $121 · 2021: $324 · 2022: $173 · 2023: $121 · 2024: $44.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $157.78 | 2019-2022 | |
| Minerva Surgical, INC | $142.47 | 2021 | |
| Hologic Sales and Service, LLC | $104.74 | 2021-2024 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $92.86 | 2020-2023 | Slynd |
| Aspira Women'S Health INC | $81.64 | 2022-2024 | Ova1 |
| Astellas Pharma US INC | $65.17 | 2020-2022 | |
| Meditrina | $57.24 | 2022 | |
| Pfizer INC. | $48.27 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $36.39 | 2019-2023 | Gardasil 9 |
| Therapeuticsmd, INC. | $23.60 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.50 | 2023 | |
| Myovant Sciences INC. | $18.42 | 2021 | |
| Scynexis, INC. | $15.40 | 2022 | |
| Mylan Pharmaceuticals INC. | $14.25 | 2020 | |
| Daiichi Sankyo INC. | $13.38 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.39 | 2020 | |
| Roche Diagnostics Corporation | $11.18 | 2019 | |
| Organon LLC | $10.49 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Kreider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.